These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6053216)

  • 1. Methane formation in vivo from N-isopropyl alpha(2-methylhydrazino)-p-toluamide hydrochloride, a tumor-inhibiting methylhydrazine derivative.
    Dost FN; Reed DJ
    Biochem Pharmacol; 1967 Sep; 16(9):1741-6. PubMed ID: 6053216
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the biochemical mode of action of a cytotoxic methylhydrazine derivative, N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide.
    Sartorelli AC; Tsunamura S
    Mol Pharmacol; 1966 Jul; 2(4):275-83. PubMed ID: 5968069
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic activation of the terminal N-methyl group of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine).
    Moloney SJ; Wiebkin P; Cummings SW; Prough RA
    Carcinogenesis; 1985 Mar; 6(3):397-401. PubMed ID: 3978755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal malformations produced in rats by N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine).
    Chaube S; Murphy ML
    Teratology; 1969 Feb; 2(1):23-31. PubMed ID: 5788825
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the mode of action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide (MIH).
    Gutterman J; Huang AT; Hochstein P
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):797-802. PubMed ID: 5773670
    [No Abstract]   [Full Text] [Related]  

  • 6. N-demethylation of p-(N1-methylhydrazion methyl)-N-isopropyl benzamide (procarbazine), a cytostatically active methylhydrazine derivative, in the intact rat and in the isolated perfused rat liver.
    Dewald B; Baggiolini M; Aebi H
    Biochem Pharmacol; 1969 Sep; 18(9):2179-86. PubMed ID: 5345891
    [No Abstract]   [Full Text] [Related]  

  • 7. Demethylation in vivo of Natulan, a tumour-inhibiting methylhydrazine derivative.
    Baggiolini M; Bickel MH; Messiha FS
    Experientia; 1965 Jun; 21(6):334-6. PubMed ID: 5870507
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm.
    Kreis W
    Cancer Res; 1970 Jan; 30(1):82-9. PubMed ID: 5441083
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidation of p-(N1-methylhydrazino methyl)-N-isopropyl benzamide (procarbazine) to the methylazo derivative and oxidative cleavage of the N2-C bond in the isolated perfused rat liver.
    Baggiolini M; Dewald B; Aebi H
    Biochem Pharmacol; 1969 Sep; 18(9):2187-96. PubMed ID: 5345892
    [No Abstract]   [Full Text] [Related]  

  • 10. SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).
    OLIVERIO VT; DENHAM C; DEVITA VT; KELLY MG
    Cancer Chemother Rep; 1964 Nov; 42():1-7. PubMed ID: 14226125
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of procarbazine [N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide HCl].
    Prough RA; Coomes MW; Cummings SW; Wiebkin P
    Adv Exp Med Biol; 1981; 136 Pt B():983-96. PubMed ID: 7046391
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection and estimation of azomethane in expired air of 1,2-dimethylhydrazine-treated rats.
    Fiala ES; Kulakis C; Bobotas G; Weisburger JH
    J Natl Cancer Inst; 1976 Jun; 56(6):1271-3. PubMed ID: 994225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia.
    Samuels ML; Leary WV; Alexanian R; Howe CD; Frei E
    Cancer; 1967 Aug; 20(8):1187-94. PubMed ID: 4291633
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the metabolic fate of the C14 labeled methyl group of a methylhydrazine derivative in P815 mouse leukemia.
    Kreis W; Piepho SB; Bernhard HV
    Experientia; 1966 Jul; 22(7):431-3. PubMed ID: 5964092
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of radioactively labelled compounds of pharmacological interest by gas-liquid radiochromatography.
    Hazelton HR; Johnson P
    Br J Pharmacol; 1970 May; 39(1):236P-237P. PubMed ID: 5420127
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative carcinogenicity of N-isopropyl-alpha-(2-methylhydraziono)-p-toluamide. HCI (procarbazine hydrochloride), its degradation products, other hydrazines, and isonicotinic acid hydrazide.
    Kelly MG; O'Gara RW; Yancey ST; Gadekar K; Botkin C; Oliverio VT
    J Natl Cancer Inst; 1969 Feb; 42(2):337-44. PubMed ID: 5765465
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic activation of hydrazines.
    Nelson SD; Gordon WP
    Adv Exp Med Biol; 1981; 136 Pt B():971-81. PubMed ID: 7344522
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative metabolic studies with Natulan, methylhydrazine and methylamine in rats.
    Schwartz DE
    Experientia; 1966 Apr; 22(4):212-3. PubMed ID: 5955980
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the tumor-inhibitory and tumor-inducing properties of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride).
    Grunberg E; Prince HN
    Chemotherapy; 1969; 14(2):65-76. PubMed ID: 5394393
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative metabolism of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine) by rat liver microsomes.
    Dunn DL; Lubet RA; Prough RA
    Cancer Res; 1979 Nov; 39(11):4555-63. PubMed ID: 498087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.